Approximately 3 out of 4 Canadians with PsA Failed to Achieve MDA within 6 months of Treatment
At the 6-month mark, between 73.2% to 78.6% of Canadian patients with psoriatic arthritis reported pain.
Source: hcplive.com
Psoriasis Activity News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Psoriasis Activity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Psoriasis Activity Today - Breaking & Trending Today
Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
Clinical Success Achieved in Second Cohort of Patients PRINCETON, N.J., Jan. 4, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and...
Source: marketscreener.com
Real-World Data Suggest Long-Term Treatment With Secukinumab Is Safe, Effective
Findings are based on a retrospective, multicenter study carried out in Spain.
Source: ajmc.com
Early Intervention with Secukinumab May Be Effective for Patients with Psoriasis
New data indicates that psoriasis patients who are naïve to biological therapies may benefit from early intervention with secukinumab, though further research is needed.
Source: hcplive.com
UNION therapeutics announces positive topline results from the IASOS Phase 2b study of oral orismilast in patients with moderate to severe psoriasis
Primary endpoint at week 16 was met for all three active doses of oral orismilast in moderate to severe patients with psoriasis. Statistical significance...
Source: prnewswire.com